Ridgepath Capital Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$683K Hold
2,080
– – 0.38% 29
2026
Q2
$901K Hold
2,080
– – 0.4% 28
2026
Q1
$444K Hold
2,080
– – 0.22% 36
2025
Q4
$279K Hold
2,080
– – 0.13% 39
2025
Q3
$279K Hold
2,080
– – 0.12% 41
2025
Q2
$202K Buy
+2,080
New +$165K 0.09% 46
2024
Q3
– Sell
-2,080
Closed -$221K – 45
2024
Q2
$221K Sell
2,080
-20
-1% -$1.92K 0.22% 38
2024
Q1
$204K Buy
+2,100
New +$185K 0.23% 44

Other funds holding LRCX

Ridgepath Capital Management's LRCX Position: Q3 2026 in Review

Ridgepath Capital Management held its Lam Research (LRCX) position steady in Q3 2026 at 2,080 shares worth $683K. The position accounts for 0.38% of the portfolio, ranked #29.

Ridgepath Capital Management first reported a position in LRCX in Q1 2024 and has held it in 8 quarters since. The position peaked at $901K in Q2 2026. 1,179 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.

  • Ridgepath Capital Management held 2,080 shares of Lam Research worth $683K as of Q3 2026.
  • Ridgepath Capital Management left its Lam Research share count unchanged in Q3 2026.
  • Lam Research made up 0.38% of Ridgepath Capital Management's portfolio in Q3 2026, its #29 holding.
  • Ridgepath Capital Management first reported a position in Lam Research in Q1 2024 and has held it in 8 quarters since.
  • Ridgepath Capital Management's Lam Research position peaked at $901K in Q2 2026.
  • 1,179 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.

Based on Ridgepath Capital Management's 13F filing for Q3 2026, filed 29 Oct 2026.